ArticleMetabolomics : open access2016

Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line.

Ghada A Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.